Get the Stockscreener App
4.30
0.00%
0.00
Pre-market:
4.20
-0.10
-2.33%
Pluri Inc stock is traded at $4.30, with a volume of 4,342.
It is up +0.00% in the last 24 hours and down -6.32% over the past month.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
See More
Previous Close:
$4.30
Open:
$4.3
24h Volume:
4,342
Relative Volume:
0.44
Market Cap:
$30.09M
Revenue:
$598.00K
Net Income/Loss:
$-21.81M
P/E Ratio:
-1.0437
EPS:
-4.12
Net Cash Flow:
$-16.66M
1W Performance:
-4.44%
1M Performance:
-6.32%
6M Performance:
-19.48%
1Y Performance:
-27.73%
1-Day Range:
$4.2001
$4.33
1-Week Range:
$4.2001
$4.43
52-Week Range:
$4.07
$6.60
Pluri Inc Stock (PLUR) Company Profile
Name
Pluri Inc
Sector
Industry
Phone
972-74-710-7171
Address
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
Compare PLUR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLUR
Pluri Inc
|
4.30 | 30.09M | 598.00K | -21.81M | -16.66M | -4.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.74 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
617.00 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
567.09 | 34.59B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.76 | 33.10B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
271.04 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Pluri Inc Stock (PLUR) Latest News
BRAINSTORM CELL THERAPEUTICS INC. SEC 10-K Report - TradingView
Pluri Inc. (NASDAQ:PLUR) Sees Large Decrease in Short Interest - Defense World
Pluri Inc. sets date for 2025 annual shareholder meeting By Investing.com - Investing.com Canada
Pluri Inc. sets date for 2025 annual shareholder meeting - Investing.com India
Revolutionary Cell Therapy Preservation: Teknova's New PluriFreeze System Transforms Development Process - StockTitan
Stem Cell Stocks on the Rise: Companies Driving the $48 Billion Market Boom - openPR
Plurilock Security (CVE:PLUR) Shares Down 5% – Here’s What Happened - Defense World
Using cell science to fight nuclear weapons: How is Pluri revolutionizing health and food tech? - The Jerusalem Post
Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Forecast: Ke... - WhaTech
Pluri Inc. partners with Hemafund for radiation emergency response By Investing.com - Investing.com Canada
Pluri Inc. and Hemafund partner for radiation emergency pre By Investing.com - Investing.com Canada
Pluri signs deal to help Ukraine's radiation emergency preparedness - The Pharma Letter
Pluri, Hemafund Sign Exclusive Collaboration Deal on Potential Radiation Treatment; Shares Rise - Marketscreener.com
Pluri Inc. and Hemafund partner for radiation emergency pre - Investing.com India
Pluri Inc. partners with Hemafund for radiation emergency response - Investing.com
Pluri announces exclusive collaboration agreement with Hemafund - TipRanks
Pluri Announces Exclusive Collaboration Agreement with Hemafund to Enhance Ukraine's Radiation Emergency Preparedness - The Manila Times
Head-To-Head Survey: Pluri (NASDAQ:PLUR) & Kyverna Therapeutics (NASDAQ:KYTX) - Defense World
EAF and Buhler announce collaboration - TipRanks
Can This New Technology Finally Make Lab-Grown Meat Affordable? Ever After Foods Says Yes - StockTitan
Pluri Announces Strategic Merger to Enhance Market Position - TipRanks
Pluri Proposes Extension of Convertible Bond Maturity to Key Investor - TipRanks
Pluri: Fiscal Q2 Earnings Snapshot - CT Insider
Pluri: Fiscal Q2 Earnings Snapshot -February 11, 2025 at 05:38 pm EST - Marketscreener.com
Pluri Inc. Faces Financial Challenges Amid Continued Innovation - TipRanks
Pluri Inc. SEC 10-Q Report - TradingView
Pluristyx Enables Safer, Universal Cell Therapy Solutions with Newly Issued U.S. Patent for iACT Stealth™ Technology - Business Wire
Pluri Ltd. Strengthens Financial Position Through Capital Raising - TipRanks
Romanian Fintech Company Pluridio is Expanding its Global Presence by Opening a Subsidiary in the UK - PR Newswire
Plurilock Security (CVE:PLUR) Trading Up 4% – Should You Buy? - Defense World
Pluri (NASDAQ:PLUR) Trading Down 4.4% – Time to Sell? - Defense World
Pluri secures additional $3.5 million investment - MSN
Pluri Secures Additional $3.5 Million Investment from Major Shareholder at Premium to Market, Bringing Total Recent Financings to $10 Million - The Manila Times
Major Shareholder Doubles Down: Pluri Lands $3.5M Premium Investment as Growth Plans Accelerate - Stock Titan
The Month In Cultivated Meat: January - substack.com
Pluri Inc. Announces Appointment of Alejandro Weinstein to Board of Directors -January 23, 2025 at 07:15 am EST - Marketscreener.com
Liberation labs raises $50.5m: The Week in AgriFoodTech - AgFunderNews
Pluri Strengthens Leadership Amid Strategic Board Appointment - TipRanks
Adipose-Derived Stem Cell Market to Reach $3013.9 Million by 2030. - openPR
Pluri Inc. granted extension to regain Nasdaq compliance - MSN
Pluri gets $6.5M investment from Alejandro Weinstein, enters cacao market - Yahoo Finance
BeZero closes $32m round: The Week in AgriFoodTech - AgFunderNews
Pluri Secures $6.5 Million Investment and Acquires Majority Stake in Cell-Based Cacao Producer Kokomodovegconomist - vegconomist - the vegan business magazine
Pluri Secures $6.5 Million Strategic Investment at Premium to Market, Enters Cacao Market Through Acquisition - The Manila Times
Pluri Secures $6.5M Premium Investment, Acquires Majority Stake in Cultivated Cacao Pioneer - StockTitan
Pluri Inc Stock (PLUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.89%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):